Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of care survey for prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 59, Issue 4, 2004, Pages 1053-1061

  Zelefsky, Michael J ^a   Moughan, Jennifer ^b   Owen, Jean ^b   Zietman, Anthony L ^c   Roach III, Mack ^d   Hanks, Gerald E ^e  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b AMERICAN COLLEGE OF RADIOLOGY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e FOX CHASE CANCER CENTER   (United States)

Author keywords

Androgen deprivation; Dose escalation; Patterns of care; Prostate cancer; Radiotherapy

Indexed keywords

HORMONES; PATIENT TREATMENT; RADIOTHERAPY; REGRESSION ANALYSIS; RISK ASSESSMENT; TUMORS;

EXTERNAL BEAM RADIOTHERAPY (ERT); PROSTATE CANCER;

ONCOLOGY;

ADULT; AGED; ANDROGEN THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL PRACTICE; HEALTH SURVEY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RADIATION DOSE; REVIEW;

EID: 3042613335     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.12.011     Document Type: Article

References (12)

1. Pollack A., Zagars G.K., Smith L.G., et al. Preliminary results of a randomized radiotherapy dose escalation study comparing 70 Gy to 78 Gy for prostate cancer. J Clin Oncol. 18:2000;3904-3911
2. Zelefsky M.J., Fuks Z., Hunt M., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol. 166:2001;876-881
3. Hanks G.E., Hanlon A.L., Pinover W.H., et al. Dose selection for prostate cancer based on dose comparison and dose response studies. Int J Radiat Oncol Biol Phys. 46:2000;823-832
4. Roach M. III, Meehan S., Kroll S., et al. Radiotherapy for high grade clinically localized adenocarcinoma of the prostate. J Urol. 156:1996;1719-1723
5. Lyons J.A., Kupelian P.A., Mohan D.S., et al. Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate. Urology. 55:2000;85-90
6. Pilepich M.V., Krall J.M., al-Sarraf M., et al. Androgen deprivation with radiation therapy compared to radiation therapy alone for locally advanced prostatic carcinoma A randomized comparative trial of the Radiation Therapy Oncology Group. Urology. 45:1995;616-623
7. Pilepich M.V., Caplan R., Byhardt R.W., et al. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy Report of Radiation Therapy Oncology Group protocol 85-31. J Clin Oncol. 15:1997;1013-1021
8. Bolla M., Gonzalez D., Warde P., et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med. 337:1997;295-300
9. American Joint Committee on Cancer. Prostate. Fleming I.D., Cooper J.S., Henson D.E., et al. AJCC cancer staging manual. 5th ed:1997;181-183 JB Lippincott, Philadelphia
10. Gleason D.F. Histologic grading and clinical staging of prostatic carcinoma. Tannenbaum M. Urologic pathology The prostate. 1977;171-197 Lea & Febiger, Philadelphia
11. Roach M, III, DeSilvio M, Lawton C, et al. Phase III trial comparing whole pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol 2003;91:1904-1911
12. Lee WR, Moughan JM, Owen J, et al. The 1999 Patterns of Care Survey of radiation therapy for localized prostate cancer - A comprehensive survey of prostate brachytherapy in the United States. Cancer. 2003;98:1981-1994